Disease | thromboembolism |
Phenotype | C1135191|systolic heart failure |
Sentences | 1 |
PubMedID- 21135601 | Several studies that have attempted to address this controversy have, as a whole, demonstrated that the rates of thromboembolic events in patients with systolic heart failure taking warfarin are similar to those in patients taking placebo, basically showing no additional protective benefit of warfarin. |
Page: 1